CRT 2017 : FDA VALVE - CRT Valve & Structural - FDA - PFO Closure: Current State and Future Directions

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA VALVE - CRT Valve & Structural - FDA - PFO Closure: Current State and Future Directions

Featuring

  • Andrew Farb
  • Richard Benson
  • Jon Resar
  • Dan Gutfinger
  • Kenneth Stein
  • David Holmes Jr
  • Rachel Neubrander
  • Megan Coylewright

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

FDA Considerations for the Labeling and Future Trials - Andrew Farb
Who Should I Refer for PFO Closure and What Studies I Would Like to See - The Neurologist Perspective - Richard Benson
Now Approved, How Do We Utilize It - Cardiology Perspective - Jon Resar
PFO Closure - Industry Perspective - Dan Gutfinger
Lessons From WATCHMAN Launch: FDA, CMS, and the Launch of a New Therapy - Kenneth Stein, MD
LAA Occlusion Post-Approval Studies: Opportunities for use of Registries - David Holmes Jr.
Looking Forward: New Clinical Trial Design – The FDA Perspective - Rachel Neubrander
Patient Selection for LAA Closure: The Role of Shared Decision Making - Megan Coylewright

Target Audience

Learning Objectives

Related Moments

CRT 2015 Technology & Innovation - Future Clinical Trial Designs and Regulatory Requirements to Assess Efficacy of Devices for the Treatment of Renal Denervation
Conference
A session on Future Clinical Trial Designs and Regulatory Requirements to Assess Efficacy of Devices for the Treatment of Renal Denervation from CRT 2015
CRT 2015 Technology & Innovation - Cardiovascular Innovations Part I
Conference
A session on Cardiovascular Innovations Part I from CRT 2015
Antiplatelet and Lipid-lowering Drugs in Hypertension
Journal
Article on Antiplatelet and Lipid-lowering Drugs in Hypertension
Loading Simple Education